Quantcast

Latest Qiagen Stories

2014-07-31 12:28:35

DUBLIN, July 31, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Genomics Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Genomics is the study of the genetic material or genomes of an organism. It is expected to be a strong basis for the discovery and development of diagnostic and therapeutic solutions for a range of human diseases or health conditions. Genomics is supported by three major product segments:...

2014-07-29 16:26:30

VENLO, the Netherlands, July 29, 2014 /PRNewswire/ -- - Achieved Q2 2014 targets: Adjusted net sales of $331.2 million (+4% CER); adjusted operating income of $81.2 million and 25% operating margin; adjusted EPS of $0.26 CER - H1 2014 adjusted net sales rise approximately 8% CER excluding U.S. HPV tests, in line with full-year 2014 goal; H1 2014 free cash flow rises 28% to $77 million...

2014-07-28 20:24:50

LONDON, July 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Genomics Market 2014-2018https://www.reportbuyer.com/product/2255162/Global-Genomics-Market-2014-2018.htmlAbout GenomicsGenomics is the study of the genetic material or genomes of an organism. It is expected to be a strong basis for the discovery and development of diagnostic and therapeutic solutions for a range of human diseases or health conditions. Genomics is supported by three...

2014-07-24 16:26:56

HILDEN, Germany, and MARSEILLE, France, July 24, 2014 /PRNewswire/ -- - Exclusive global license from University of Tokyo enables development of QIAGEN assays for SF3B1 mutations, including next-generation sequencing (NGS) gene panels, for blood cancers - Mutations of SF3B1 gene, to be targeted by new test, indicate favorable prognosis for patients with bone marrow disorders known as myelodysplastic syndromes - QIAGEN...

2014-05-23 20:21:52

GERMANTOWN, Maryland and HILDEN, Germany, May 23, 2014 /PRNewswire/ -- - Clinically proven companion diagnostic gains U.S. approval to guide use of Amgen's Vectibix(R) (panitumumab) in treatment of metastatic colorectal cancer - FDA approval (PMA) of therascreen KRAS RGQ PCR Kit for Vectibix expands QIAGEN's leadership in molecular companion diagnostics for personalized healthcare - QIAGEN driving the adoption of molecular tests...

2014-05-20 16:26:37

HILDEN, Germany and GERMANTOWN, Maryland, May 20, 2014 /PRNewswire/ -- - New biomedical content resources strengthen QIAGEN's industry-leading bioinformatics portfolio - Expansion will offer clinical researchers the most comprehensive, high-quality and up-to-date literature source for gene variant and disease phenotype associations - Expert-curated hereditary variants from HGMD are now available to customers using...

2014-05-06 16:33:13

VENLO, The Netherlands, May 6, 2014 /PRNewswire/ -- SOURCE QIAGEN N.V.

2014-05-05 16:27:10

GERMANTOWN, Maryland, and HILDEN, Germany, May 5, 2014 /PRNewswire/ -- - FDA clearance for QIAsymphony RGQ MDx, a complete sample-to-result automation platform, marks a milestone for one of QIAGEN's major global growth drivers - U.S. launch of artus C. difficile QS-RGQ MDx Kit will provide a reliable molecular test for a widespread healthcare-associated infection - QIAGEN continues to advance pipeline with additional FDA...

2014-04-16 08:30:31

GERMANTOWN, Md., April 16, 2014 /PRNewswire/ -- -- Investment of $10 million in Germantown and Frederick campuses brings QIAGEN's total recent commitment in Maryland to $50 million -- Germantown campus becomes state-of-the-art research, manufacturing and office site for Molecular Diagnostics with consolidation of activities from Gaithersburg site -- Germantown site passes FDA pre-approval inspection to manufacture digene HC2 HPV Test --...

2014-04-10 16:24:24

HILDEN, Germany and VIENNA, April 10, 2014 /PRNewswire/ -- - Reliable diagnostic tools under development for mutations of calreticulin (CALR) are expected to benefit patients with blood disorders known as myeloproliferative neoplasms - QIAGEN acquired exclusive worldwide license for CALR biomarker from CeMM Vienna, whose researchers recently published the discovery in the New England Journal of...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related